## Abstract Neuroleptic malignant syndrome is the rarest and the most serious of the neuroleptic induced movement disorders. Although potent neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs may also be a cause of NMS. Three databases were searched using the terms β
Olanzapine associated weight gain, Hyperglycemia and Neuroleptic Malignant Syndrome: case report
β Scribed by Rhonda Malyuk; Bruce Gibson; Ric M. Procyshyn; Nirmal Kang
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 47 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.596
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We describe here a case of olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome in a 64 yearβold woman with a significant medical history. Eighteen weeks after initiating olanzapine, Mrs X lost glycemic control, exhibited signs and symptoms consistent with neuroleptic malignant syndrome and gained 8.9 kg. We suggest that utilization of olanzapine in the less medically stable geriatric patient be implemented with vigilant monitoring for such complications mentioned above. Copyright Β© 2002 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
A 30-year-old white man with schizophrenia developed anorexia and nausea, and was admitted to hospital for confusion and delirium. He was on olanzapine, 10 days prior to admission. On admission, typical neuroleptic malignant syndrome (NMS) developed with elevated body temperature (39.7 degrees C), o
## Abstract An elderly patient with probable dementing illness was treated with haloperidol and trifluoperazine for control of agitation. The patient developed neuroleptic malignant syndrome characterized by cogwheel rigidity, deterioration in sensorium, hyperpyrexia, mutism, autonomic dysfunction,